Cargando…
Prevention Strategies to Minimize the Infection Risk Associated with Biologic and Targeted Immunomodulators
The introduction of biologic and targeted immunomodulators is a significant breakthrough in the therapeutic area of various fields of medicine. The occurrence of serious infections, a complication of secondary immunosuppression associated with these agents, leads to increased morbidity and mortality...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035951/ https://www.ncbi.nlm.nih.gov/pubmed/32110062 http://dx.doi.org/10.2147/IDR.S233137 |